China's lab monkey shortage delays drug development, prices double in a year
Prices for cynomolgus macaques used in biomedical research have doubled in China within a year, with one state laboratory paying around $26,000 per animal in June. Biotech executives describe securing research primates as comparably difficult to sourcing Nvidia chips amid tight global supply. The shortage is pushing back preclinical toxicology studies by four to ten months, eroding China's competitive edge in drug development timelines. Zheshang Securities estimates an annual supply deficit of 15,000 to 20,000 monkeys persisting through 2028. Increased imports from Cambodia are expected to partially ease the shortfall.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.




Discussion (0)
Log in to join the discussion and vote.
Log in